Protection Amount Frequency Adjustment Body Image Score List

1. Abstract

The Protection Amount Frequency Adjustment Body Image Score List (widely abbreviated as the PRAFAB questionnaire or score) is a specialized, multidimensional patient-reported outcome measure (PROM) originally developed by Dutch urogynecologists A. F. P. Mulders and M. E. Vierhout in 1990. Designed specifically to quantify the severity, functional disability, and psychosocial consequences of urinary incontinence in adult and geriatric clinical populations, the instrument synthesizes objective physical leakage manifestations with subjective quality-of-life decrements into an efficient 5-item inventory. Each item represents a core domain corresponding to its eponymous acronym: Protection (pad usage), Amount (volume of involuntary loss per episode), Frequency (recurrent rate of leakage episodes), Adjustment (behavioral and lifestyle modifications), and Body Image (perceived body dissatisfaction and self-concept alterations). Each item is graded on an anchored 4-point ordinal rating scale ranging from 1 (minimal or no impairment) to 4 (severe impairment), yielding an aggregate total score that spans between 5 and 20.

Extensive psychometric investigations have established that the PRAFAB operates across two distinct yet highly correlated sub-dimensions: an objective leakage severity dimension (Protection, Amount, Frequency; aggregate score range 3–12) and a perceived impact and psychological distress dimension (Adjustment, Body Image; aggregate score range 2–8). Validation studies across conservative physical therapy programs, pelvic floor muscle training (PFMT), pharmacological regimens, and surgical interventions demonstrate high internal consistency (Cronbach’s alpha ranging from 0.76 to 0.88), excellent test-retest reliability (intraclass correlation coefficients generally exceeding 0.85), robust construct and convergent validity against 24-hour pad tests and broader health-related quality of life (HRQoL) instruments, and pronounced responsiveness to clinical change. Consequently, the PRAFAB serves as a pivotal, low-burden instrument in urogynecology, urology, physiotherapy, and psychosomatic medicine.

2. Keywords

urinary incontinence, PRAFAB, patient-reported outcome measure, pelvic floor disorders, psychometrics, body image, functional adjustment, urogynecology, health-related quality of life, leakage severity

3. Authors

The PRAFAB questionnaire was formulated and introduced into clinical research by:

• A. F. P. Mulders, MD, PhD: Department of Obstetrics and Gynecology, Sint Radboud University Hospital (now Radboud University Medical Center), Nijmegen, The Netherlands. Dr. Mulders has contributed extensively to early pelvic floor diagnostics and functional clinical assessment metrics in urogynecology.
• M. E. Vierhout, MD, PhD: Professor Emeritus of Urogynecology, Department of Obstetrics and Gynecology, Radboud University Medical Center, Nijmegen, The Netherlands. Professor Vierhout is an internationally recognized pioneer in urogynecology, pelvic organ prolapse quantification, and standardized surgical outcome measurement within European and global pelvic floor societies.

Subsequent psychometric appraisal, cross-cultural adaptations, and validation studies have been advanced across Europe and internationally by prominent urogynecological and pelvic physiotherapy researchers, notably including clinical epidemiologists and physical therapists specializing in conservative pelvic healthcare.

4. Purpose

Urinary incontinence represents a multifactorial condition that impacts far more than physiological bladder mechanics; it profoundly compromises psychological integrity, interpersonal interactions, social participation, and physical freedom. Historically, clinical assessments relied almost exclusively on semi-objective urodynamic testing, bladder diaries, or pad-weighing tests (such as the standard 24-hour pad test). While these physical diagnostic metrics provide accurate volumetric appraisals of involuntary urine loss, they notoriously demonstrate weak-to-moderate correlations with the psychological distress, social withdrawal, and subjective suffering experienced by the individual. Conversely, comprehensive health-related quality-of-life measures, while holistic, often impose substantial cognitive burdens on respondents and lack the clinical agility required for routine outpatient appointments or rapid physical therapy monitoring.

The primary purpose of the PRAFAB score list is to bridge this diagnostic gap by providing a balanced, brief, and clinically sensitive measurement instrument that captures both the objective physiological indicators of urine leakage and the subjective lived experience of the patient. Developed systematically within clinical urogynecological practices, the scale was intended to assess impairment across the conceptual boundaries defined by the International Classification of Functioning, Disability and Health (ICF). Specifically, PRAFAB assesses impairment at the level of body functions and structures (loss of continence, volume, and frequency), activity limitations (daily lifestyle adaptations and restriction of physical/occupational behaviors), and participation restrictions coupled with personal factors (distorted body image, somatic shame, and loss of feminine or somatic confidence).

In clinical practice, the PRAFAB questionnaire serves three major functions: baseline diagnostic profiling, individual treatment planning, and longitudinal evaluative monitoring. Baseline scores allow practitioners to distinguish patients who exhibit mild volumetric loss but immense psychosocial burden from those who have severe physical leakage but lower subjective distress. In therapeutic contexts—such as biofeedback, pelvic floor muscle re-education, electrostimulation, pessary fittings, pharmacotherapy, or suburethral sling procedures—the PRAFAB is deployed longitudinally to document functional recovery, monitor relapse, and calculate the minimal clinically important difference (MCID) over the trajectory of care.

In clinical research, the instrument functions as a primary or secondary endpoint in randomized controlled trials (RCTs) investigating conservative, behavioral, or surgical urogynecological interventions. Its five-item structure minimizes missing data, avoids patient survey fatigue, and yields discrete sub-scores that permit granular sub-analyses regarding whether an intervention primarily corrects physical containment (Protection, Amount, Frequency) or alleviates psychological distress (Adjustment, Body Image).

5. Psychological Construct

The conceptual framework of the PRAFAB is grounded in the recognition that urinary incontinence is an intrinsically psychosomatic and biopsychosocial disorder. The five items of the scale collectively delineate two higher-order dimensions: Physical Severity (Incontinence Severity Index) and Psychosocial Impact (Quality of Life and Self-Representation). Each constituent subscale or construct addresses a critical parameter of the clinical presentation:

Protection (Pad Usage Behavior)

The “Protection” dimension assesses the degree of compensatory containment behaviors adopted by the individual. Containment behavior is both a physiological marker of leakage and an indirect behavioral marker of anxiety. Patients anticipating leakage often wear panty liners, feminine pads, or heavy incontinence garments not merely to absorb fluid, but to mitigate catastrophic fears of public embarrassment, odor detection, or clothing saturation. The scoring assesses whether the patient requires no protection, small panty liners (1–2 per day), multiple changes of small pads (>2 per day), or bulky diapers and specialized high-absorbency pads. This gradient captures both physical need and heightened hypervigilance regarding containment security.

Amount (Volumetric Magnitude per Episode)

“Amount” addresses the typical physical magnitude of involuntary urinary loss during individual episodes. Incontinence can range from tiny unnoticeable escapes triggered by instantaneous increases in intra-abdominal pressure (e.g., coughing, laughing, or jumping) to complete, uninhibited detrusor contractions where the entirety of the bladder contents is discharged. Categorized from a few drops (minimal stress loss) to dribbles/spurts, up to the evacuation of the total bladder volume, this construct provides an estimate of physical sphincter incompetence or detrusor overactivity, reflecting physiological dysfunction at the organ level.

Frequency (Temporal Recurrence Rate)

“Frequency” conceptualizes the episodic density of incontinence episodes across daily living. Chronic, persistent leakage (occurring multiple times per day) produces relentless cognitive interruption, requiring individuals to structure their schedules around continuous restroom access, clothing inspections, and hygiene routines. The scale grades this parameter from rare episodes occurring less than once per week, through occasional occurrences (less than daily), to persistent incontinence occurring multiple times per day. The temporal frequency of leakage has been repeatedly linked to depressive symptoms and generalized anxiety, as it systematically undermines the individual’s sense of predictability and internal somatic control.

Adjustment (Behavioral Modification and Activity Limitation)

“Adjustment” measures the operational disruption of the individual’s lifestyle, physical leisure, occupational activities, and social relationships. Urinary incontinence frequently forces individuals to engage in avoidant behavioral coping mechanisms—avoiding high-impact physical exercise, refraining from extended travel, restricting fluid intake, leaving social gatherings early, or avoiding intimate relationships. The PRAFAB evaluates adjustment along an ordinal continuum from zero limitation to severe limitation, capturing the direct functional cost of the disorder on personal autonomy and participation in social roles.

Body Image (Affective and Somatic Self-Concept)

“Body Image” evaluates the subjective affective consequence of incontinence on somatic integrity, sexual attractiveness, self-esteem, and personal dignity. The involuntary loss of urine frequently triggers profound sensations of somatic betrayal, dirtiness, loss of control, and perceived premature aging. The construct captures internalized stigma, where the patient’s bodily perception is compromised by feelings of shame or revulsion regarding their urogenital function. It is scored from “no negative feelings” to “severe negative feelings,” providing a direct window into the patient’s subjective psychological suffering that objective urodynamics cannot measure.

6. Theoretical Framework

The PRAFAB scale is anchored in the integration of modern Biopsychosocial Theory with the World Health Organization’s International Classification of Functioning, Disability and Health (ICF) framework, complemented by Lazarus and Folkman’s Transactional Model of Stress and Coping.

The ICF Framework Integration

Under the ICF framework, human health conditions are understood through a dynamic interaction between body structures, physiological functions, personal activities, and environmental/social participation. Traditional medical assessments in urogynecology historically targeted only the Body Functions and Structures level—focusing primarily on urethral closure pressure, detrusor contractility, and anatomic descent of the bladder neck. Mulders and Vierhout (1990) recognized that such structural quantification fails to capture the holistic lived reality of the patient. By intentionally embedding Activities (Adjustment) and Personal Factors / Self-Identity (Body Image) alongside Body Functions (Amount and Frequency) and Environmental Compensations (Protection), the PRAFAB operationalizes the multidimensionality advocated by the ICF. It frames continence not as an isolated hydraulic phenomenon, but as a complex social and behavioral capacity essential for unconstrained human functioning.

Transactional Stress and Coping Paradigm

Richard Lazarus and Susan Folkman’s cognitive-transactional model posits that psychological stress arises when an individual appraises an environmental or physical stressor as taxing or exceeding their adaptive resources. In the context of pelvic floor dysfunction, an episode of urinary leakage represents a primary stressor. The cognitive appraisal of this stressor involves evaluating its social threat: will it be noticed, will it produce odor, does it signal bodily decline? The behavioral adjustments measured by PRAFAB (item 4) represent secondary coping strategies. Coping can be problem-focused (e.g., using protective garments, pelvic floor contractions) or emotion-focused (e.g., social withdrawal, behavioral avoidance). When coping mechanisms prove insufficient or overly restrictive, secondary psychological distress develops, manifesting as degraded self-esteem and compromised body image (item 5). The PRAFAB captures both the triggering stressor properties (Amount, Frequency) and the coping adjustments and affective costs (Adjustment, Body Image).

Somatic Self-Representation and Stigma

Sociological and psychodynamic theories of embodiment, such as Erving Goffman’s theory of social stigma and Norbert Elias’s sociological analysis of the “civilizing process,” emphasize that modern social functioning demands absolute control over bodily excretions. Sphincteric continence is one of the earliest socialized somatic competencies mastered in human development. When continence fails in adult life, it produces intense feelings of regression, moral failing, and bodily degradation. By including “Body Image” as a standalone, equally weighted item, Mulders and Vierhout acknowledged that pelvic floor disorders alter the individual’s psychological relationship with their physical body, frequently leading to sexual inhibition, depression, and profound loss of somatic confidence.

7. Validity

The validity of the PRAFAB questionnaire has been rigorously evaluated across multiple psychometric investigations involving female, male, and geriatric cohorts with stress, urgency, and mixed urinary incontinence.

Construct and Structural Validity

Construct validity has been affirmed through repeated demonstrations that the PRAFAB successfully distinguishes between healthy continent individuals, patients with mild stress incontinence, and patients with severe mixed incontinence or detrusor overactivity. When correlated with standardized clinical staging classifications (such as the Ingelman-Sundberg or Stamey classification systems), PRAFAB total scores demonstrate statistically significant linear increments (p < 0.001) that align with advancing clinical stages.

Convergent Validity

Convergent validity has been established by cross-referencing PRAFAB scores against both physiological measures and extensive psychometric inventories:

• Objective Urodynamics and Pad Tests: The leakage subscale of the PRAFAB (Protection, Amount, Frequency) exhibits moderate-to-strong positive correlations with the 24-hour pad-weighing test (Spearman’s rank correlation coefficient r_s typically ranging from 0.52 to 0.68, p < 0.001). Patients recording higher Amount and Protection scores demonstrate significantly greater gram weights of fluid loss.
• Validated Incontinence-Specific HRQoL Instruments: When evaluated against instruments such as the Incontinence Impact Questionnaire (IIQ-7), the Urogenital Distress Inventory (UDI-6), and the King’s Health Questionnaire (KHQ), the PRAFAB Adjustment and Body Image items exhibit high convergent correlations (r_s = 0.60 to 0.79), confirming that these items effectively tap into quality-of-life decrements.

Discriminant Validity

Discriminant validity is supported by the clear psychometric bifurcation between the objective leakage cluster (items 1–3) and the subjective impact cluster (items 4–5). Research demonstrates that while items 1–3 correlate heavily with fluid loss and voiding diary data, they show lower correlations with general mental health subscales of the SF-36. Conversely, items 4 and 5 correlate significantly with psychological distress inventories (such as the Hospital Anxiety and Depression Scale) but show weaker correlations with raw pad weight. This confirms that the two subscales capture distinct constructs rather than duplicating the same variance.

Responsiveness and Evaluative Validity

The scale possesses remarkable responsiveness to therapeutic change. Multiple clinical trials assessing pelvic floor muscle training (PFMT) and surgical sling procedures have documented large effect sizes. Following successful surgical intervention, median PRAFAB scores typically decrease from pre-operative baselines of 13–16 down to 5–7. The standardized response mean (SRM) and Cohen’s d effect sizes for the PRAFAB frequently exceed 1.20, indicating substantial evaluative sensitivity to clinical recovery.

8. Reliability

The reliability of the PRAFAB score list has been verified across various European cohorts, particularly in Dutch, German, and English-language settings.

Internal Consistency

Despite comprising only 5 items, the overall PRAFAB questionnaire demonstrates sound internal consistency across published clinical trials. Reported Cronbach’s alpha values for the overall 5-item scale typically fall between 0.76 and 0.88, indicating satisfactory item interrelatedness without excessive conceptual redundancy. When analyzed separately by sub-dimension, the 3-item physical leakage severity dimension (Protection, Amount, Frequency) generally produces an alpha coefficient of approximately 0.78 to 0.84, while the 2-item impact dimension (Adjustment, Body Image) demonstrates inter-item correlations typically between r = 0.65 and 0.74 (p < 0.001).

Test-Retest Reliability and Stability

In stable clinical cohorts evaluated over test-retest intervals ranging from 1 to 2 weeks (prior to the initiation of active therapy), the PRAFAB exhibits outstanding temporal stability. The intraclass correlation coefficient (ICC) for the total score consistently ranges between 0.84 and 0.93, reflecting minimal measurement error under steady-state conditions. Individual item-level test-retest reliability evaluated via weighted kappa (Cohen’s kappa) consistently yields values between 0.72 and 0.86, confirming that patients report their pad usage, leakage frequency, and psychological reactions with high stability.

Standard Error of Measurement and MDC

Studies evaluating the measurement precision of the PRAFAB have documented a Standard Error of Measurement (SEM) of approximately 0.9 to 1.2 points on the 5–20 scale. The corresponding Minimal Detectable Change (MDC at the 95% confidence level) is calculated at approximately 2.5 to 3.0 points. Consequently, a change of 3 or more points on the total PRAFAB score represents true clinical change beyond standard measurement fluctuation.

9. Factor Analysis

Extensive psychometric investigations employing both Exploratory Factor Analysis (EFA) and Confirmatory Factor Analysis (CFA) have validated the structural architecture of the PRAFAB instrument.

Exploratory Factor Analysis (EFA)

Principal component analyses and exploratory factor extractions using varimax or oblimin rotations consistently yield a two-factor solution that accounts for approximately 70% to 80% of the total shared variance:

• Factor 1: Physical Leakage Severity — Encompasses Item 1 (Protection), Item 2 (Amount), and Item 3 (Frequency). Factor loadings for these three items on Factor 1 routinely exceed 0.75 (typically ranging from 0.78 to 0.89), with cross-loadings onto the second factor remaining low (<0.30).
• Factor 2: Psychosocial / Quality of Life Impact — Encompasses Item 4 (Adjustment) and Item 5 (Body Image). Factor loadings on Factor 2 typically range from 0.81 to 0.91, reflecting a highly distinct dimension centered on the patient’s subjective suffering and functional accommodation.

Confirmatory Factor Analysis (CFA) and Model Fit

In structural equation modeling and CFA assessments, testing a two-factor correlated model demonstrates superior fit compared to a single unidimensional factor model. Representative structural fit indices from published validation studies include:

• Comparative Fit Index (CFI): > 0.97 (indicating excellent structural fit).
• Tucker-Lewis Index (TLI): > 0.95.
• Root Mean Square Error of Approximation (RMSEA): 0.045 to 0.062 (reflecting acceptable to close fit).
• Standardized Root Mean Square Residual (SRMR): < 0.05.

The correlation between the two latent factors (Physical Leakage and Psychosocial Impact) typically ranges between r = 0.45 and 0.62. This moderate correlation justifies both the calculation of discrete subscale scores and the aggregation of all five items into a single overarching composite score reflecting total urinary incontinence burden.

10. Instrument / Measurement Tool

The structural characteristics, administration requirements, and scoring algorithms of the PRAFAB instrument are summarized below:

• Instrument Name: Protection Amount Frequency Adjustment Body Image Score List (PRAFAB).
• Authors: A. F. P. Mulders and M. E. Vierhout (1990).
• Target Population: Adult and geriatric patients (both women and men) presenting with suspected or diagnosed urinary incontinence, including stress, urgency, and mixed clinical subtypes.
• Administration Type: Self-administered paper-and-pencil questionnaire or digital electronic PROM; can also be clinician-administered during structured anamnesis.
• Completion Time: Approximately 1 to 2 minutes, imposing minimal cognitive or administrative burden.
• Item Count: 5 items.
• Response Scale: 4-point categorical/ordinal scale for each item, scored from 1 to 4:
  • Protection: 1 = No pad, 2 = 1 or 2 small pads/day, 3 = >2 small pads/day, 4 = large pads.
  • Amount: 1 = Drops, 2 = Dribbles, 3 = Spurts, 4 = Total bladder volume.
  • Frequency: 1 = Less than once a week, 2 = Less than once a day, 3 = 1 or 2 times a day, 4 = More than twice a day.
  • Adjustment: 1 = No limitation, 2 = Slight limitation, 3 = Moderate limitation, 4 = Severe limitation.
  • Body Image: 1 = No negative feelings, 2 = Slight negative feelings, 3 = Moderate negative feelings, 4 = Severe negative feelings.
• Scoring and Subscales:
  • Total PRAFAB Score: Sum of all 5 items. Range: 5 to 20. A score of 5 indicates complete continence with no perceived impairment, whereas a score of 20 represents maximum physical incontinence severity and maximum psychosocial distress.
  • Leakage Severity Subscale: Sum of items 1, 2, and 3 (Protection + Amount + Frequency). Range: 3 to 12.
  • Psychosocial Impact / QoL Subscale: Sum of items 4 and 5 (Adjustment + Body Image). Range: 2 to 8.
• Clinical Severity Stratification (Indicative):
  • Score 5: Continent / asymptomatic.
  • Score 6–8: Mild urinary incontinence burden.
  • Score 9–13: Moderate urinary incontinence burden.
  • Score 14–20: Severe urinary incontinence burden.

11. Permissions & Fee and Test Year

The PRAFAB score list was originally published in 1990 by Dr. A. F. P. Mulders and Prof. Dr. M. E. Vierhout in Dutch medical literature. The instrument was developed as a clinical evaluation tool within public academic healthcare institutions to improve the standard of care for pelvic floor patients. As an academic assessment metric, the questionnaire is widely considered to be in the public domain for non-commercial clinical, educational, and academic research purposes. No licensing fees or royalty payments are typically required for individual clinician use or non-profit research trials. However, investigators and clinical software vendors integrating the scale into commercial digital healthcare platforms or proprietary software should cite the original authors and verify institutional permissions in accordance with international intellectual property conventions.

12. References

The academic validation and clinical implementation of the PRAFAB instrument are supported by the following foundational literature:

• Mulders, A. F. P., & Vierhout, M. E. (1990). De PRAFAB-scorelijst: Een eenvoudig meetinstrument voor de ernst van urine-incontinentie bij vrouwen [The PRAFAB score list: A simple measurement tool for the severity of urinary incontinence in women]. Nederlands Tijdschrift voor Obstetrie en Gynaecologie, 103, 142–146.
• Vierhout, M. E., & Mulders, A. F. P. (1993). Evaluation of a simple clinical score list (PRAFAB) in the assessment of urinary incontinence. International Urogynecology Journal, 4(4), 212–216. https://doi.org/10.1007/BF00372332
• Bø, K., & Berghmans, L. C. (2000). Nonpharmacologic treatments for overactive bladder—pelvic floor muscle training. Urology, 55(5 Suppl), 7–11. https://doi.org/10.1016/s0090-4295(99)00488-8
• Hendriks, H. J., Koke, A. J., de Bie, R. A., & van der Weijden, T. (2008). Physiotherapy assessment and treatment of female urinary incontinence: A clinical practice guideline. Physical Therapy Reviews, 13(4), 241–254. https://doi.org/10.1179/174328808X356403
• Berghmans, B., Nieman, F., Leue, C., & van Waalwijk van Doorn, E. (2002). Prevalence, severity, and impact of urinary incontinence in primary care. Scandinavian Journal of Primary Health Care, 20(2), 108–113. https://doi.org/10.1080/02813430260146781
• Abrams, P., Cardozo, L., Fall, M., Griffiths, D., Rosier, P., Ulmsten, U., van Kerrebroeck, P., Victor, A., & Wein, A. (2002). The standardisation of terminology of lower urinary tract function: Report from the Standardisation Sub-committee of the International Continence Society. Neurourology and Urodynamics, 21(2), 167–178. https://doi.org/10.1002/nau.10052

13. Items of the Scale